Dendritic cells cultured from mononuclear cells and CD34 cells in myeloma do not harbour human herpesvirus 8

G. M. Cull, J. M. Timms, A. P. Haynes, N. H. Russell, W. L. Irving, Jonathan Ball, B. J. Thomson

Research output: Contribution to journalArticlepeer-review

29 Citations (Scopus)

Abstract

Dendritic cells (DC) are antigen-presenting cells with the potential to be a powerful adjuvant in the immunotherapy of haematological malignancy, including myeloma. Recently, human herpesvirus 8 (HHV-8) infection of dendritic cells in the long-term bone marrow stromal cultures of patients with myeloma has been reported. This finding is of great potential importance regarding oncogenesis in myeloma in addition to having significant implications for the use of DC in the immunotherapy of this disease. Therefore DC generated from mobilized blood mononuclear cells (MO-DC) and purified CD34+ cells (CD34-DC) of myeloma patients were examined for the presence of HHV-8 using a sensitive PCR technique. HHV-8 was not demonstrated in MO-DC or CD34-DC and we conclude that these cells remain a suitable vehicle for investigation in the immunotherapy of myeloma.
Original languageEnglish
Pages (from-to)793-796
Number of pages4
JournalBritish Journal of Haematology
Volume100
Issue number4
DOIs
Publication statusPublished - 1 Jan 1998
Externally publishedYes

Keywords

  • Dendritic cells
  • Human herpesvirus 8
  • Immunotherapy
  • Myeloma

Fingerprint

Dive into the research topics of 'Dendritic cells cultured from mononuclear cells and CD34 cells in myeloma do not harbour human herpesvirus 8'. Together they form a unique fingerprint.

Cite this